The paper discusses the antibacterial mechanism of cefiderocol, highlighting its unique cell entry through a siderophore strategy and its stability against various β-lactamases. It emphasizes cefiderocol's effectiveness against multidrug-resistant Gram-negative bacteria, including carbapenem-resistant strains.